
Core Viewpoint - Cosmos Health Inc. has initiated the purchase of Ethereum (ETH) as part of its digital asset treasury reserve strategy, marking a significant step towards integrating cryptocurrency into its financial strategy [1][2]. Group 1: Company Strategy - The company has completed an initial purchase of $1 million in ETH, utilizing a financing facility of up to $300 million with a U.S.-based institutional investor [1]. - CEO Greg Siokas expressed enthusiasm about building an ETH treasury, indicating a shift from holding only cash to incorporating assets with strong appreciation potential [2]. - The strategic move is supported by the growing adoption of ETH by institutional investors, its inclusion in ETFs, and the proposed expansion of cryptocurrency access in retirement plans [2]. Group 2: Company Overview - Cosmos Health Inc. is a diversified, vertically integrated global healthcare group, incorporated in 2009 in Nevada [3]. - The company owns a portfolio of proprietary pharmaceutical and nutraceutical brands and operates under European Good Manufacturing Practices (GMP) [3]. - Cosmos Health is expanding its global distribution platform and has established R&D partnerships targeting major health disorders, enhanced by AI drug repurposing technologies [3].